Key Record Dates
ClinicalTrials.gov Identifier: | NCT04659629 |
---|---|
Brief Title: | NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer |
First Submitted : | November 9, 2020 |
First Submitted that Met QC Criteria : | December 2, 2020 |
First Posted : | December 9, 2020 |
Last Update Submitted that Met QC Criteria : | November 30, 2022 |
Last Update Posted : | December 2, 2022 |